Ireland takes action to improve access to cancer screening for disabled people
Ireland takes action to improve access to cancer screening for disabled people Breast, cervical and bowel screening more accessible for disabled people HSE National Screening Service Ireland’s HSE National Screening Service is taking action to make breast, cervical and bowel screening more accessible for disabled people. Grounded in research with disabled people, Ireland is implementing […]
Putting equity at the heart of cancer screening: Ireland’s approach
Putting equity at the heart of cancer screening Ireland’s approach HSE National Screening Service Ireland’s HSE National Screening Service is taking action to make cancer screening more equitable – for everyone. Through our Choose Screening strategy, a dedicated Equity Framework and Equity Action Plan, Ireland is embedding equity in all aspects of its breast, cervical […]
Supporting partnership, excellence and equity in cervical screening
Supporting partnership, excellence and equity in cervical screening The role of Ireland’s CervicalCheck Screening Training Unit The role of Ireland’s CervicalCheck Screening Training Unit CervicalCheck’s Screening Training Unit (STU) is a cornerstone of Ireland’s national cervical screening programme. By providing education, training and support to healthcare professionals – from novice to experienced sample takers – […]
Partnership, equity and a shared vision: Ireland’s progress towards cervical cancer elimination
Partnership, equity and a shared vision Ireland’s progress towards cervical cancer elimination Cervical Cancer Elimination By 2040, Ireland aims to make cervical cancer rare in every community. Ireland’s experience offers an example of how coordinated national action, partnership, community engagement and system-wide collaboration can turn global goals into local progress. A clear national commitment Ireland […]
Thermal ablation: cost-effective and safe for the treatment of cervical precancer
Thermal ablation: cost-effective and safe for the treatment of cervical precancer Evidence from 15 years of research supports a portable thermal ablator for cervical precancer treatment, especially in low-resource settings Thermal ablation: cost-effective and safe for the treatment of cervical precancer Published by IARC on 17 November 2025, this evidence summary (No 7) reports on […]
Colposcopy Training Masterclass in Riga
Colposcopy Training Masterclass in Riga A Step Towards Unified and High-Quality Cervical Cancer Prevention Across Europe Colposcopy Training Masterclass in Riga At the end of October, the Riga Stradins University (RSU) Institute of Public Health hosted a masterclass for colposcopy training specialists as part of the project Implementation of cancer screening programmes (EUCanScreen). The training […]
Belgium Cervical Cancer Screening Programme
Belgium: Screening Campaign Country Cervical Cancer Screening Programme What is the Cervical Cancer Screening Programme? In Flanders, women aged 25 to 64 are invited to take part in the Cervical Cancer Screening Programme, organised by the Flemish Government.The programme offers a free smear test (Pap test) every three years to detect early cell changes before […]
Towards Smarter, More Precise and More Effective Healthcare – Insights from the Conference on Personalised Cancer Screening in Riga, Latvia
Latvia, Riga, 08-10-2025 Towards Smarter, More Precise and More Effective Healthcare – Insights from the Conference on Personalised Cancer Screening in Riga, Latvia Insights from the Conference on Personalised Cancer Screening in Riga, Latvia On 8 October, the international conference “Personalised Cancer Screening – Lessons Learned and the Way Forward” took place in Riga, at […]
Belgium Advances Cervical Cancer Prevention with HPV-Based Screening
Belgium Advances Cervical Cancer Prevention with HPV-Based Screening Transitioning from Pap test screening to primary HPV-based screening Belgium Advances Cervical Cancer Prevention with HPV-Based Screening Brussels, Belgium — Effective 1 January 2025, Belgium has officially transitioned from cytology-based (Pap test) screening to primary HPV-based screening for cervical cancer. This marks a major advancement in evidence-based […]
International Conference in Riga on Personalised Cancer Screening Brings Together Europe’s Leading Experts
Latvia, Riga, 08-10-2025 International Conference in Riga on Personalised Cancer Screening Brings Together Europe’s Leading Experts Personalised Cancer Screening Conference On 8 October, the international conference “Personalised Cancer Screening – Lessons Learned and the Way Forward” took place at the University of Latvia in Riga. Organised as part of the EUCanScreen Joint Action, the […]